FDA Clearance Tracker · K263232
eplex RP3 Control M530; eplex RP3 Negative
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 30, 2026
Substantially Equivalent
Time to decision
44 days
Received Sep 16, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K263232
- Device name
- eplex RP3 Control M530; eplex RP3 Negative
- Applicant location
- Saco, ME
- Received
- Sep 16, 2026
- Decided
- Oct 30, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN)
- Device class
- Class II
- Regulation
- 21 CFR 866.3920
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PMN. The earliest in FDA's data is DEN150058, decided Mar 28, 2016.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K263232
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Maine Molecular Quality Controls, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262573 · Decided Oct 21, 2026 · 86 days after receipt
Device type: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN) · Laboratory Medicine & Pathology
K260577 · Decided May 19, 2026 · 88 days after receipt
Device type: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN) · Laboratory Medicine & Pathology
K251526 · Decided Aug 14, 2025 · 87 days after receipt
Device type: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays (PMN) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.